Health Invest Partners Ab has filed its 13F form on November 04, 2025 for Q3 2025 where it was disclosed a total value porftolio of $231 Million distributed in 38 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $28.4M, Abb Vie Inc. with a value of $21.3M, Neurocrine Biosciences Inc with a value of $14.4M, Merck & Co., Inc. with a value of $13.5M, and Thermo Fisher Scientific Inc. with a value of $13.2M.
Examining the 13F form we can see an increase of $9.46M in the current position value, from $221M to 231M.
Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.